Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103629
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103629
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103629
Oesophageal cancer-specific mortality risk and public health insurance: Prospective cohort study from China
Xiang-Lin Wu, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China
Xiao-Sheng Li, Hai-Ke Lei, Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing 400030, China
Jing-Han Cheng, Lin-Xin Deng, Research Center for Medicine and Social Development, Chongqing Medical University, Chongqing 400016, China
Zu-Hai Hu, Department of Health Statistics, School of Public Health, Chongqing Medical University, Chongqing 400016, China
Jun Qi, Department of Thoracic Surgery, The People’s Hospital of Changshou Chongqing, Chongqing 401220, China
Co-first authors: Xiang-Lin Wu and Xiao-Sheng Li.
Co-corresponding authors: Jun Qi and Hai-Ke Lei.
Author contributions: Lei HK and Hu ZH contributed to conception and analysis the data; Wu XL and Li XS contributed to acquisition and drafting of the paper; Cheng JH and Deng LX contributed to interpretation of data and revising it critically for intellectual content; Qi J and Lei HK contributed to conception or design of the work and final approval of the version to be published; All authors agree to be accountable for all aspects of the work.
Supported by the Chongqing Science and Health Joint Medical Research Project, No. 2024MSXM065.
Institutional review board statement: The studies involving human participants were reviewed and approved by The Ethics Committee of Chongqing University Cancer Hospital (No. CZLS2023338-A).
Clinical trial registration statement: This study did not require clinical registration.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrolment.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Data sharing statement: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hai-Ke Lei, PhD, Associate Professor, Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, No. 181 Hanyu Road, Shapingba District, Chongqing 400030, China. tohaike@163.com
Received: November 26, 2024
Revised: January 9, 2025
Accepted: February 8, 2025
Published online: April 15, 2025
Processing time: 120 Days and 8.7 Hours
Revised: January 9, 2025
Accepted: February 8, 2025
Published online: April 15, 2025
Processing time: 120 Days and 8.7 Hours
Core Tip
Core Tip: The study reveals the intricate relationship between public health insurance, out-of-pocket payment ratios, and oesophageal cancer-specific mortality. It underscores the importance of insurance policy optimization to mitigate the mortality risk among high-risk groups and emphasizes the role of early intervention strategies in improving patient outcomes.